Hohimer Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Hohimer Wealth Management's PFE Position: Q2 2024 in Review
Hohimer Wealth Management sold out of Pfizer (PFE) in Q2 2024, closing a stake of 47,328 shares — an estimated $1.31M sold.
Hohimer Wealth Management first reported a position in PFE in Q4 2019 and held it in 18 quarters. The position peaked at $5.74M in Q4 2021. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.
- Hohimer Wealth Management reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
- Hohimer Wealth Management sold 47,328 Pfizer shares in Q2 2024, an estimated $1.31M.
- Hohimer Wealth Management first reported a position in Pfizer in Q4 2019 and held it in 18 quarters.
- Hohimer Wealth Management's Pfizer position peaked at $5.74M in Q4 2021.
- 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.
Based on Hohimer Wealth Management's 13F filing for Q2 2024, filed 2 Aug 2024.